{"id":140712,"date":"2026-04-24T10:59:05","date_gmt":"2026-04-24T10:59:05","guid":{"rendered":"https:\/\/my.legal500.com\/guides\/?post_type=comparative_guide&#038;p=140712"},"modified":"2026-04-24T14:56:54","modified_gmt":"2026-04-24T14:56:54","slug":"cyprus-venture-capital","status":"publish","type":"comparative_guide","link":"https:\/\/my.legal500.com\/guides\/chapter\/cyprus-venture-capital\/","title":{"rendered":"Cyprus: Venture Capital"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-140712","comparative_guide","type-comparative_guide","status-publish","hentry","guides-venture-capital","jurisdictions-cyprus"],"acf":[],"appp":{"post_list":{"below_title":"<div class=\"guide-author-details\"><span class=\"guide-author\">Yiasemis LLC<\/span><span class=\"guide-author-logo\"><img src=\"https:\/\/my.legal500.com\/guides\/wp-content\/uploads\/sites\/1\/2026\/04\/yiasemis-Y-mark-final-3000-1.jpg\"\/><\/span><\/div>"},"post_detail":{"above_title":"<div class=\"guide-author-details\"><span class=\"guide-author\">Yiasemis LLC<\/span><span class=\"guide-author-logo\"><img src=\"https:\/\/my.legal500.com\/guides\/wp-content\/uploads\/sites\/1\/2026\/04\/yiasemis-Y-mark-final-3000-1.jpg\"\/><\/span><\/div>","below_title":"<span class=\"guide-intro\">This country specific Q&amp;A provides an overview of Venture Capital laws and regulations applicable in Cyprus<\/span><div class=\"guide-content\"><div class=\"filter\">\r\n\r\n\t\t\t\t<input type=\"text\" placeholder=\"Search questions and answers...\" class=\"filter-container__search-field\">\r\n\t\t\t<\/div>\r\n\r\n\t\t\t\r\n\r\n\r\n\t\t\t<ol class=\"custom-counter\">\r\n\r\n\t\t\t\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are there specific legal requirements or preferences regarding the choice of entity and\/or equity structure for early-stage businesses that are seeking venture capital funding in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>There is no legal requirement to use a particular entity type. In practice, the private limited liability company incorporated under the Cyprus Companies Law, Cap. 113, is overwhelmingly the vehicle of choice for early-stage businesses raising venture capital in Cyprus. Cap. 113 imposes no minimum share capital on private companies and allows multiple classes of shares with tailored rights, which makes it well suited to the layered equity structures that venture investors expect. A Cyprus private company is used either as the operating entity or as a holding company above an operating subsidiary where cross-border operations or tax planning are anticipated.<\/p>\n<p>Where a Cyprus holding company is used, founders should pay attention to substance. Banks and the tax authorities increasingly expect demonstrable local activity \u2014 a properly constituted board, meetings held in Cyprus, books and records kept locally, and Cyprus-based staff where appropriate \u2014 if the company is to be treated as genuinely resident here.<\/p>\n<p>We have developed a structure-selection and substance roadmap for early-stage founders that we make available on our pro bono website (<a href=\"http:\/\/www.yiasemis.law\">link<\/a>).<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the principal legal documents for a venture capital equity investment in the jurisdiction and are any of them publicly filed or otherwise available to the public?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>A venture capital equity investment in Cyprus is documented using a standard common law suite:<\/p>\n<ul>\n<li>a non-binding term sheet;<\/li>\n<li>a subscription agreement containing the company\u2019s (and usually the founders\u2019) representations and warranties, conditions precedent, and closing deliverables;<\/li>\n<li>a shareholders\u2019 agreement governing board composition, reserved matters, information rights, transfer restrictions, anti-dilution protection, and exit mechanics;<\/li>\n<li>amended and restated articles of association reflecting the new share class(es); and<\/li>\n<li>a disclosure letter qualifying the warranties.<\/li>\n<\/ul>\n<p>At earlier stages, the investment is often documented on a convertible note or SAFE rather than a full subscription and shareholders&#8217; agreement package.<\/p>\n<p>Of the main investment documents, only the articles of association are publicly filed. The subscription agreement, shareholders\u2019 agreement, and disclosure letter remain private.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Is there a venture capital industry body in the jurisdiction and, if so, does it provide template investment documents? If so, how common is it to deviate from such templates and does this evolve as companies move from seed to larger rounds?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>There is no Cyprus venture capital industry body producing standard-form investment documents, and no local equivalent to the BVCA or NVCA templates.<\/p>\n<p>In practice the market adapts BVCA documentation for UK-influenced rounds and NVCA or Y Combinator documentation for US-influenced rounds, localised for Cyprus law. At seed and angel stage, a short-form SAFE or convertible note is increasingly common, with full equity documentation expected at the first priced institutional round. Deviation from any template is the norm \u2014 light and founder-friendly at seed, markedly more comprehensive from Series A.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are there any general merger control, anti-trust\/competition and\/or foreign direct investment regimes applicable to venture capital investments in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Two regimes are potentially relevant for a typical VC round: merger control and FDI screening.<\/p>\n<p><em>Merger control.<\/em> Filing with the Commission for the Protection of Competition is required where three cumulative thresholds are met: at least two of the undertakings concerned each have worldwide turnover above \u20ac3.5m; at least two generate turnover in Cyprus; and aggregate Cyprus turnover of all undertakings concerned exceeds \u20ac3.5m. In practice the vast majority of VC rounds fall outside the regime.<\/p>\n<p><em>FDI screening.<\/em> Cyprus\u2019s FDI screening regime under Law 194(I)\/2025 came into force on 2 April 2026 and is the most active new constraint on cross-border deals. Notification to the Ministry of Finance is mandatory \u2014 and closing cannot occur before approval \u2014 where all three of the following apply: the investment confers a qualifying holding (25% or more of share capital and\/or voting rights); the value is at least \u20ac2 million; and the target operates in one of the listed strategic sectors (notably AI, cybersecurity, financial services, data processing, critical infrastructure, and dual-use technologies). \u2018Foreign investor\u2019 covers non-EU\/EEA\/Swiss natural persons and third-country undertakings, and the notification obligation also reaches through to any entity that is 25%-or-more owned or controlled by such an investor \u2014 a material point for fund structures with non-EU limited partners. The statutory timeline is up to 85 working days from a complete application and, where relevant, should be built into conditions precedent and long-stop dates from term sheet stage.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What is the process, and internal approvals needed, for a company issuing shares to investors in the jurisdiction and are there any related taxes or notary (or other fees) payable?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Issuing new shares in a Cyprus private company requires a board resolution allotting the new shares at the agreed price, an update to the register of members, and the issue of share certificates. Existing shareholders must also waive any pre-emption rights reserved to them under the articles and, where the company lacks sufficient unissued authorised capital or needs a new class of shares, pass the necessary resolutions and adopt amended articles. A return of allotment is filed with the Registrar within one month.<\/p>\n<p>The filing fee is nominal and there is no notary requirement. Capital duty on share issues was abolished in 2018, and stamp duty has been abolished in full with effect from 1 January 2026: subscription agreements, shareholders\u2019 agreements, and related documents executed from 2026 onwards are no longer subject to stamp duty at all.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How prevalent is participation from investors that are not venture capital funds, including angel investors, family offices, high net worth individuals, and corporate venture capital?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Non-fund investors play a meaningful role, particularly at seed and pre-Series A stages where domestic institutional capital has historically been thin.<\/p>\n<p>Angel investors are the most visible group, active in technology, fintech, and gaming. Their participation is currently supported by Article 9A of the Income Tax Law (due to expire at the end of 2026), which allows individuals to deduct up to 50% of a risk-finance investment in a qualifying innovative SME (certified as such by the Ministry of Finance) from their taxable income, subject to an annual cap of \u20ac150,000 and a three-year holding period. High net worth individuals also invest directly through angel networks or equity crowdfunding platforms.<\/p>\n<p>Family offices are a meaningful source of non-fund capital. They typically take minority positions, co-invest rather than lead, and are less governance-intensive than institutional investors.<\/p>\n<p>Corporate venture capital is limited but developing. Very few Cyprus corporates operate a dedicated venture arm with its own committed capital; most corporate investment is made directly from the parent balance sheet, on an ad hoc strategic basis, typically as minority stakes or alongside accelerator programmes.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What is the typical investment period for a venture capital fund in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>The typical investment period for a Cyprus VC fund is three to five years from first close, consistent with international market practice. Funds are generally structured with a ten-year life and two one-year extensions, so follow-on capacity for reserves and bridges usually continues for several years beyond the end of the active deployment period.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the key investment terms which a venture investor looks for in the jurisdiction including representations and warranties, class of share, board representation (and observers), voting and other control rights, redemption rights, anti-dilution protection and information rights?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>The key investment terms on a Cyprus VC round track UK and other common law practice closely.<\/p>\n<p><em>Class of share and liquidation preference.<\/em> At seed stage, priced rounds use ordinary shares, while SAFEs and convertibles remain a common alternative. From Series A, investors subscribe for a new class of preference shares carrying a 1x non-participating liquidation preference, conversion to ordinary shares on IPO or at the holder&#8217;s election, and anti-dilution protection. The liquidation waterfall is heavily negotiated where multiple preference classes are outstanding.<\/p>\n<p><em>Representations and warranties. <\/em>The company gives a standard warranty package; founders give fundamental warranties (title to shares, capacity, authority) and sometimes limited business warranties. Fundamental warranties are uncapped and unlimited in time; business warranties are capped and typically survive 12 to 24 months.<\/p>\n<p><em>Board representation.<\/em> A lead investor typically takes one seat at Series A; smaller and bridge investors more commonly receive observer rights. Composition also feeds into Cyprus tax residency and substance analysis (see Question 1).<\/p>\n<p><em>Voting and control.<\/em> Investor consent rights \u2014 \u2018reserved matters\u2019 \u2014 are central and typically cover share issues, amendments to the articles, related-party transactions, material contracts or borrowings above agreed thresholds, IP disposals, changes to the business, and insolvency. Consents are usually exercisable by a majority of investors rather than by each investor individually. Weighted voting rights on director-removal resolutions (a \u2018Bushell v Faith\u2019 clause) are an established technique for entrenching founder or investor nominee directors.<\/p>\n<p><em>Anti-dilution and redemption.<\/em> Broad-based weighted average is the market standard. Redemption rights are uncommon at early stages; at later rounds, investors sometimes negotiate redeemable preference shares (redeemable out of distributable profits after, say, five years if no exit has occurred) or a put option against the founders.<\/p>\n<p><em>Pre-emption, drag and tag.<\/em> Pre-emption rights on new share issues are standard, with larger investors sometimes reserving a right of first refusal. Drag-along rights are customary from Series A and are drafted into the articles so as to bind all shareholders, including future holders. The drag is typically exercisable by a specified majority, including a majority of the preference shareholders, to compel a sale to a bona fide third-party buyer. Tag-along rights are equally common, giving minority investors the right to join a controlling sale on the same terms.<\/p>\n<p><em>Information rights.<\/em> Monthly management accounts, quarterly reports, annual audited accounts, annual budget and plan, and reasonable inspection rights are all standard.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the key features of the liability regime (e.g. monetary damages vs. compensatory capital increase) that apply to venture capital investments in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Cyprus is a common law jurisdiction, and the liability regime is based on contract. Breach of a representation or warranty gives rise to a claim for damages measured on a diminution-in-value basis.<\/p>\n<p>Cyprus does not have the civil law concept of a \u2018compensatory capital increase\u2019 as a statutory remedy. However, equity-based adjustment mechanisms \u2014 a conversion-ratio adjustment or the issue of bonus shares at nominal value \u2014 are increasingly used as contractual remedies for defined warranty or indemnity events. As with leaver mechanics (see Question 13), these adjustments are best structured as primary obligations triggered by the defined warranty or indemnity event, rather than as liquidated damages for breach, to avoid being unenforceable under the Cyprus rule against penalties.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How common are arrangement\/ monitoring fees for investors in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Arrangement and monitoring fees are not a standard feature of early-stage Cyprus VC deals. Arrangement fees are sometimes seen at growth stage or in more structured transactions, typically at 1% to 2% of the investment and netted off the subscription price. Monitoring fees are more associated with private equity buyouts.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are founders and senior management typically subject to restrictive covenants following ceasing to be an employee and\/or shareholder and, if so, what is their general scope and duration?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Founders and senior management are typically subject to restrictive covenants in the investment documents, principally a non-compete in the company&#8217;s actual business and non-solicitation of customers, suppliers and employees. Durations typically run for 12-24 months under the shareholders&#8217; agreement and 6-12 months under the employment contract, with geographic reach limited to Cyprus or the territories in which the company is actively trading. The framework on enforceability is, however, materially stricter in Cyprus than in comparable jurisdictions such as England: Cyprus contract law treats any agreement restrictive of a person&#8217;s freedom to carry on a lawful trade or profession as void, subject only to narrow exceptions (principally sale-of-goodwill and partnership dissolution), and the appellate case law is too thin for the position to be regarded as settled.<\/p>\n<p>Practically, we approach this in two ways. First, we rely more heavily on non-solicitation than on non-competes, as non-solicitation is more readily characterised as protecting specific relationships rather than restricting trade generally. Second, we structure the commercially important restrictions as shareholder covenants rather than employment covenants, which gives them a more defensible footing under the narrow Cyprus exceptions.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How are employees typically incentivised in venture capital backed companies (e.g. share options or other equity-based incentives)?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Share options are the primary equity incentive tool in Cyprus VC-backed companies, and their attractiveness was materially improved by the 2026 tax reform.<\/p>\n<p>Under the new regime (Article 20D of the Income Tax Law), gains on exercise of options granted under a qualifying employer plan are taxed at a flat 8% rate rather than at the individual\u2019s marginal rate. The main conditions are that the plan must have been approved by the Commissioner of Taxation before grants are made (on a per-beneficiary basis); the minimum exercise price must be at least 50% of market value at the approval date; options must vest over at least three years; and the benefit eligible for the 8% rate is capped at twice the employee\u2019s annual remuneration in the relevant year, with an additional \u20ac1 million cap per rolling ten-year period. Options granted to connected persons do not qualify.<\/p>\n<p>Phantom equity, cash-settled schemes and restricted stock units are seen occasionally but remain uncommon.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the most commonly used vesting\/good and bad leaver provisions that apply to founders\/ senior management in venture capital backed companies?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Vesting and leaver provisions in Cyprus broadly follow international market convention.<\/p>\n<p>Vesting. The standard founder schedule is four years with a one-year cliff, applied to existing founder shares at the first institutional round (not just to new grants) \u2014 effectively re-vesting the founders&#8217; equity as a condition of investment. Employee options follow the same vesting pattern. Where acceleration is provided on a change of control, double-trigger (acceleration only if the founder is also terminated without cause following the sale) is the prevailing approach.<\/p>\n<p>Good and bad leaver. A good leaver typically includes death, permanent incapacity, retirement, and termination without cause; a bad leaver covers voluntary resignation without good reason, termination for gross misconduct, or material breach of the shareholders&#8217; agreement or employment contract. A good leaver typically retains vested shares or receives fair value for them; a bad leaver transfers all shares at the lower of cost and nominal value.<\/p>\n<p>Two statutory points shape the drafting. Private companies cannot buy back their own shares, so the leaver mechanism operates as a compulsory transfer to the remaining shareholders or a nominee, usually backed by a call option in favour of the investors. And Cyprus contract law retains a strict rule against penalties: a transfer price that is mechanically punitive risks being unenforceable, so bad leaver transfers should be drafted as call options or primary transfer obligations triggered by the leaver event itself, rather than as liquidated damages for breach.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What have been the main areas of negotiation between investors, founders, and the company in the investment documentation, over the last 24 months?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Negotiation in Cyprus VC documentation over the last 24 months has reflected a mix of global trends and Cyprus-specific developments.<\/p>\n<p><em>Valuation and down-round protection.<\/em> A more cautious global environment has pushed investors to press harder on anti-dilution and liquidation preferences. Bridge and extension financings via SAFEs and convertible notes have also become more common, bringing valuation caps, discount rates, most-favoured-nation provisions and conversion mechanics into sharper negotiation.<\/p>\n<p><em>Founder vesting and option pools.<\/em> Investors have increasingly insisted on re-vesting existing founder shares at the first institutional round, with bad leaver definitions a common friction point. Option pool size (market range 10% to 15%) and whether the pool is pre- or post-money are recurring negotiation points.<\/p>\n<p><em>FDI screening.<\/em> The new regime has added a real conditions-precedent issue to cross-border rounds \u2014 long-stop dates, regulatory risk allocation, and information sharing are all being drafted more carefully than they were.<\/p>\n<p><em>Tax reform.<\/em> The 2026 tax reform \u2014 the introduction of the 15% corporate rate and the 8% options regime (see Question 12), the abolition of stamp duty, and changes to dividend taxation \u2014 has added a new tax layer to deal negotiation, principally around option plan design and pre-closing structuring<em>.<\/em><\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How prevalent is the use of convertible debt (e.g. convertible loan notes) and advance subscription agreement\/ SAFEs in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>The use of convertible loan notes and SAFE-style instruments has grown materially in Cyprus over the last few years, driven by the influence of US and UK early-stage practice.<\/p>\n<p>Convertible loan notes are the more established of the two, most often used at pre-seed and seed stage, either as a bridge ahead of a contemplated priced round or as standalone seed financing where the parties want to defer valuation. SAFEs (based on the Y Combinator model) and Advance Subscription Agreements are increasingly common, particularly among founders with US connections and among angel investors and family offices familiar with the instrument.<\/p>\n<p>Share allotments by Cyprus companies require a board resolution and, in some cases, shareholder approval. SAFEs and convertible loan notes are both contractual commitments to allot shares on a future trigger, so the relevant corporate approvals should be in place at execution to ensure the allotment obligation can be performed at conversion. Well-drafted Cyprus-law SAFEs and CLNs deal with this by building those approvals in upfront rather than leaving them to be obtained at conversion.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the customary terms of convertible debt (e.g. convertible loan notes) and advance subscription agreement\/ SAFEs in the jurisdiction and are there standard form documents?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>There are no standard-form local documents. Practitioners adapt international precedents \u2014 most commonly the BVCA convertible note template or the Y Combinator SAFE \u2014 for Cyprus law.<\/p>\n<p><em>Convertible loan notes.<\/em> Principal amounts range from \u20ac50,000 to \u20ac500,000 at seed, with bridge notes ahead of a Series A typically larger. Interest accrues at 5% to 8% per annum and rolls up into the conversion. Maturity is usually 12 to 24 months. Conversion mechanics typically include a 15% to 25% discount and, increasingly, a valuation cap, with a qualifying round usually defined by a minimum aggregate raise of \u20ac500,000 to \u20ac1 million.<\/p>\n<p><em>SAFEs.<\/em> The post-money SAFE is now the prevalent form for US-influenced deals. The economic terms are the valuation cap and\/or the discount; there is no interest, no maturity, and no obligation to repay. Pro-rata rights and most-favoured-nation provisions are commonly negotiated.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">How prevalent is the use of venture or growth debt as an alternative or supplement to equity fundraisings or other debt financing in the last 24 months?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Venture and growth debt is still a very early-stage product in Cyprus and cannot yet be described as established. The reason is primarily on the supply side: the traditional Cypriot banking sector operates on a collateral-based lending model poorly suited to asset-light, high-growth startups, and there is no domestic specialist venture lender. Where growth debt has been accessed by Cyprus-based companies, it has typically been sourced from international specialist venture lenders.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the customary terms of venture or growth debt in the jurisdiction and are there standard form documents?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>There are no standard-form local documents and no established domestic market practice. Where venture or growth debt has been accessed, documentation has been driven by the lender \u2014 typically an international specialist provider \u2014 on Loan Market Association-style precedents adapted for Cyprus security and enforcement, with commercial terms tracking international market norms.<\/p>\n<p>Cyprus-specific drafting focuses on security. The typical package is a floating charge over the company&#8217;s assets supplemented by fixed charges over specific high-value assets. All charges must be registered with the Registrar of Companies within 21 days of creation; an unregistered charge is void against the liquidator and any creditor of the company.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">What are the current market trends for venture capital in the jurisdiction (including the exits of venture backed companies) and do you see this changing in the next year?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Cyprus is at an inflection point in its venture capital market. The ecosystem has moved from a largely informal and externally dependent funding environment to one with emerging domestic institutional infrastructure, growing international recognition, and an increasingly supportive regulatory and tax framework. The trajectory is positive, though challenges remain.<\/p>\n<p>On the positive side, Cyprus&#8217;s startup ecosystem has shown measurable momentum. StartupBlink&#8217;s November 2025 report identified Cyprus as the fastest-climbing EU country in its Global Startup Ecosystem Index \u2014 a ranking based on startup numbers, funding activity, and ecosystem quality. Domestic institutional infrastructure is also beginning to take shape: the recently established Cyprus Equity Fund \u2014 a state-backed fund focused on pre-seed and seed-stage companies with a Cyprus connection \u2014 has put meaningful local capital into the seed market, and the Research and Innovation Foundation, the government body overseeing research and innovation in Cyprus, has been an active source of grant funding for early-stage startups. The most significant recent development is the April 2026 launch of the Plug and Play Innovation Centre in Cyprus, which will support 60 startups over three years through cohort-based accelerator programmes and access to Plug and Play&#8217;s global corporate-partner and investor network. Participation is conditional on Cyprus incorporation.<\/p>\n<p>Structural challenges remain: Cyprus ranks near the bottom of EU member states by VC investment as a share of GDP; most capital raised by Cyprus-based companies comes from abroad; and the domestic exit market is limited, with most exits occurring through cross-border M&amp;A. Against this backdrop, the next 12 months are likely to see continued growth in deal volume at seed and early stage.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\t\t\t\t\t<li class=\"question-block filter-container__element\">\r\n\t\t\t\t\t\t<h3 class=\"filter-container__match-html\">Are any developments anticipated in the next 12 months, including any proposed legislative reforms that are relevant for venture capital investors in the jurisdiction?<\/h3>\r\n\t\t\t\t\t\t<button id=\"show-me\">+<\/button>\r\n\t\t\t\t\t\t<div class=\"question_answer filter-container__match-html\" style=\"display:none;\"><p>Several developments over the next 12 months are directly relevant to VC investors in Cyprus.<\/p>\n<p><em>FDI screening bedding in.<\/em> The FDI regime under Law 194(I)\/2025 (see Question 4) came into force on 2 April 2026 and is the most immediate operational change for cross-border investors.<\/p>\n<p><em>Angel investor incentive.<\/em> The Article 9A angel investor incentive (see Question 6) is authorised only until the end of 2026. No extension has been legislated at the time of writing, and its expiry without renewal would remove a significant structural support for early-stage investment.<\/p>\n<p><em>Merger control reform.<\/em> A 2025 consultation on amendments to the merger control thresholds has not yet been legislated but could affect notification analysis for growth-stage deals.<\/p>\n<\/div>\r\n\r\n\r\n\t\t\t\t\t<\/li>\r\n\r\n\t\t\t\t\r\n<div class=\"word-count-hidden\" style=\"display:none;\">Estimated word count: <span class=\"word-count\">3824<\/span><\/div>\r\n\r\n\t\t\t<\/ol>\r\n\r\n<script type=\"text\/javascript\" src=\"\/wp-content\/themes\/twentyseventeen\/src\/jquery\/components\/filter-guides.js\" async><\/script><\/div>"}},"_links":{"self":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/comparative_guide\/140712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/comparative_guide"}],"about":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/types\/comparative_guide"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/guides\/wp-json\/wp\/v2\/media?parent=140712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}